References
- 1. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of CRC. N Engl J Med 2000; 343: 1603-7.
- 2. Cancer screening in the European Union: report on the implementation of the Council. Available Jan 14, 2014 from: http://ec.europa.eu/health/ph_determinants/genetics/documents/cancer_screening.pdf
- 3. Haug U, Hundt S, Brenner H. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests. Am J Gastroenterol 2010; 105: 682-90.
- 4. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, et al. A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med 2005; 142: 86-94.
- 5. Steele RJC, Kostourou I, Clements PM, Watling C, Libby G, Weller D, et al. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010; 17: 68-74.
- 6. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for CRC: patient response and detection rates. J Natl Cancer Inst 2005; 97: 347-57.
- 7. Shastri YM, Loitsch S, Hoepffner N, Povse N, Hanisch E, Rösch W, et al. Comparison of an established simple office-based immunological FOBT with fecal tumor pyruvate kinase type M2 (M2-PK) for colorectal cancer screening: prospective multicenter study. Am J Gastroenterol 2008; 103: 1496-1504.
- 8. The American Cancer Society. Global cancer facts & figures. 2nd ed. Atlanta: American Cancer Society, 2011.
- 9. The guide to medicare preventive services for physicians, suppliers and other health care professionals, CMS, Dept. of Health and Human Services- USA, 2005. Available Jan 13, 2014 from: http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-MLN/MLNProducts/downloads/psguid.pdf.
- 10. Church TR, Yeazel MW, Jones RM, Kochevar LK, Watt GD, Mongin SJ, et al. A randomized trial of direct mailing of fecal occult blood test to increased CRC screening. J Natl Cancer Inst 2004; 96: 770-80.
- 11. Seifert B, Zavoral M, Fric P, Bencko V. The role of primary care in colorectal cancer screening: experience from Czech Republic. Neoplasma 2008; 55: 74-80.
- 12. Berchi C, Dupuis JM, Launoy G. The reasons of general practitioners for promoting CRC mass screening in France. Eur J Health Econ 2006; 7: 91-8.
- 13. Brawarsky P, Brooks DR. Effect of physician recommendation and patient adherence on rates of CRC testing. Cancer Detect Prev 2004; 28: 260-8.
- 14. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Available Jan 10, 2014 from: http:// www.kolorektum.cz/res/file/guidelines/CRC-screening-guidelines-EC-2011-02-03.pdf
- 15. Faivre J, Dancourt V, Lejeune C. Screening for colorectal cancer with immunochemical faecal occult blood tests. Dig Liver Dis 2012; 44: 967-73.
- 16. McCaffery K, Wardle J, Waller J. Knowledge, attitudes, and behavioral intentions in relation to the early detection of colorectal cancer in the United Kingdom. Prev Med 2003; 36: 525-35.
- 17. National Centre on Health Information and Analysis. Mortality by main causes in the Republic of Bulgaria, 2011. Available Jan 10, 2014 from: http://ncphp.government.bg/files/nczi/izdania_2010/buletin_Death_11.pdf , last access
- 18. Damyanov D, Kurtev P. Present state and perspectives in CRC treatment. Scr Sci Med 2007; 39(Suppl): 217-21.
- 19. Jatoi I, Anderson WF. Cancer screening. Curr Probl Surg 2005; 42: 620-82.
- 20. van Dam L, Hol L, de Bekker-Grob EW, Steyerberg EW, Kuipers EJ, Habbema JD, et al. What determines individuals’ preferences for colorectal cancer screening programmes? A discrete choice experiment. Eur J Cancer 2010; 46: 150-9.
- 21. Dimova R, R. Stoyanova, B. Levterova, R. Dimov. ‘Doctor-patient compliance’ in introducing of fecal immunochemical occult blood test - cross - sectional survey in Bulgaria. Euras J Fam Med 2012; 2: 55-62.
- 22. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and CRCs: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 2012; 43: 97-118.
- 23. Chachevski N. Screening in the general medical practice: PhD thesis. Plovdiv: Faculty of Public Health, Medical University, 2009.
- 24. Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med 2005; 41: 23-9.
- 25. Dimova R, Dimov R. Attitudes, motivation and behavior of general practitioners toward performance of colorectal carcinoma screening programme. General Medicine 2007; 9: 6-11.
- 26. Dimitrova D. Factors limiting the participation of patients in screening programs. In: Scientific conference 4-5. 11. 2009: proceedings. Plovdiv: Union of Scientists in Bulgaria, Scientific Researchers of the Union of Scientists in Bulgaria, 2010: 108-12.
- 27. Census 2011 in Bulgaria. Available Jan 6, 2014 from: 28. http://www.nsi.bg/census2011/PDOCS2/Census2011final_en.pdf